Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study

NCT04444336 | Unknown DMC

• 1 other identifier: REK125510-16
• Study Type: observational
• Target: 4,000
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study aims to investigate the association between the use different information sources to obtain information about the COVID-19 pandemic and symptoms of psychopathology (i.e., depression and anxiety). Research Question: How central are different sources of information used to obtain knowledge about the COVID-19 pandemic in network along with depressive and anxiety symptoms? Which sources of information are most strongly connected to different symptoms of depression and anxiety? Staying away from information will be measured in the present study. As avoidance is a type of safety behavior in anxiety disorders, we are further eager to investigate the centrality of this behavior in the network. Furthermore, multiple studies using latent-variable paradigms have established a relationship between sum-scores of depression and social anxiety use in general. We are further interested in examining this potential link more thoroughly and detailed in the present network study. The findings of this study, although they will be cross-sectional and require further examination in studies with temporal data structure, will be an important and interesting starting point giving initial ideas about potential mechanisms that may be involved in use of information sources in pandemics and mental health

Conditions

Depression; Anxiety

Outcome Measures

Primary Outcomes (2)

• The Patient Health Questionnaire 9

  The Patient Health Questionnaire 9 (PHQ-9; Kroenke, Spitzer \& Williams, 2001) is used to measure symptoms of depression in accordance with the diagnostic criteria for major depressive disorder. The questionnaire consists of nine items where each is scored on a four-point Likert scale (0-3), with the range of scores from 0 to 27. Higher scores indicate greater depression severity, and scores above 10 are considered as the cut-off that indicating that the patient is within the depressive area.

  Data is set to be collected starting from 22nd of June until enough data has been collected. The data collection period will last no longer than three weeks.

• Generalized Anxiety Disorder 7

  The Generalized Anxiety Disorder 7 (GAD-7; Spitzer, Kroenke, Williams \& Löwe, 2006) is a questionnaire consisting of seven items measuring symptoms of anxiety and worry. The items are scored on a four-point Likert scale (0-3), with the scores ranging from 0 to 21. Specific cut-off for Norwegian samples have been found yielding a cut-off of 8 and above for high sensitivity and specificity (Johnson, Ulvenes, Øktedalen \& Hoffart, 2019).

  Data is set to be collected starting from 22nd of June until enough data has been collected. The data collection period will last no longer than three weeks.

Interventions

Cross-sectional study examining the impact of information sources to obtain information about COVID-19 on depression and anxiety symptoms BEHAVIORAL

Cross-sectional study examining the impact of information sources to obtain information about COVID-19 on depression and anxiety symptoms

Eligibility Criteria

• Age: 18 Years+
• Gender Eligibility Details: Both Biological Sex and self-representation of gender are measured
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

All adults above 18 years residing in Norway and thus experiencing identical mitigation protocols are invited to participate the study, reached through a random digital sample, providing consent digitally.

You may qualify if:

• Eligible participants are all adults including those of 18 years and above,
• Who are currently living in Norway and thus experiencing identical NPIs, and
• Who will provide digital consent to partake in the study.

You may not qualify if:

• Children and adolescents (individuals below 18)
• Adults not residing in Norway during the measurement period

Sponsors & Collaborators

• University of Oslo: lead
• Modum Bad: collaborator

Related Publications (3)

• Fried EI, Cramer AOJ. Moving Forward: Challenges and Directions for Psychopathological Network Theory and Methodology. Perspect Psychol Sci. 2017 Nov;12(6):999-1020. doi: 10.1177/1745691617705892. Epub 2017 Sep 5.

  PMID: 28873325 BACKGROUND

• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

  PMID: 11556941 BACKGROUND

• Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.

  PMID: 16717171 BACKGROUND

MeSH Terms

Conditions

Depression; Anxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior; Mental Disorders

Study Officials

• Omid Ebrahimi, Double PhD Candidate

  University of Oslo

  PRINCIPAL INVESTIGATOR

• Asle Hoffart, PhD

  Modum Bad

  PRINCIPAL INVESTIGATOR

• Sverre Urnes Johnson, PhD

  University of Oslo

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Omid V. Ebrahimi, Double PhD Candidate

CONTACT

+47-22845295; omideb@uio.no

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: June 21, 2020
• First Posted: June 23, 2020
• Study Start: June 22, 2020
• Primary Completion: July 13, 2020
• Study Completion: July 13, 2020
• Last Updated: June 24, 2020

Record last verified: 2020-06